Estatísticas para RT 1654 2019 - Pembrolizumabe para Carcinoma Urotelial - NATJUS TJMG
Total de visitas
| views | |
|---|---|
| RT 1654 2019 - Pembrolizumabe para Carcinoma Urotelial - NATJUS TJMG | 11 |
Total visitas por mês
| views | |
|---|---|
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 5 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 1 |
| July 2025 | 0 |
Visitas Arquivos
| views | |
|---|---|
| RT 1654.pdf | 6 |